SABCS 2020: Reflections in HER2+ Breast Cancer | Supplements And Featured Publications

Dr. Rao on Emerging Treatments in HER2+ Metastatic Breast Cancer

December 17, 2020

Ruta D. Rao, MD, associate professor in the Department of Medicine, Division of Hematology at Rush Medical College, as well as the director of the Coleman Foundation Comprehensive Breast Cancer Clinic and medical director of Rush University Cancer Center, discusses emerging treatments for patients with HER2-positive metastatic breast cancer.

x